BOSTON SCIENTIFIC CORPORATION Stock Repurchase Program, Authorized Amount
BOSTON SCIENTIFIC CORPORATION (BSX) had Stock Repurchase Program, Authorized Amount of $1.00 billion as of 2020-12-14, per its 10-Q filed 2024-11-01.
Financial Statements › Notes › Equity
us-gaap:StockRepurchaseProgramAuthorizedAmount1 · last filed 2024-11-01
- 2020-12-14: Stock Repurchase Program, Authorized Amount $1.00B.
- 2013-12-31: Stock Repurchase Program, Authorized Amount $1.00B.
- 2013-01-25: Stock Repurchase Program, Authorized Amount $1.00B.
| Period end | Stock Repurchase Program, Authorized Amount |
|---|---|
| 2020-12-14 | $1.00B 10-Q · filed 2024-11-01 |
| 2013-12-31 | $1.00B 10-K · filed 2015-02-25 |
| 2013-01-25 | $1.00B 10-K · filed 2022-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |